Berry Global Group, Inc. Reports Fourth Quarter and Fiscal Year 2021 Results
Berry Global Group reported strong fourth quarter results with net sales of $13.9 billion, a 22% increase year-over-year. Fiscal year net income per share rose 28% to $5.30, while adjusted EPS increased 20% to $5.80. Despite facing challenges from inflation and supply chain issues, the company achieved 4% organic volume growth. For fiscal year 2022, Berry expects 2% organic volume growth and adjusted EPS between $7.20 and $7.70. Cash flow from operations is projected at $1.7-$1.8 billion, aiming for free cash flow of $900 million to $1 billion.
- Net sales growth of 22% in Q4 and 18% for fiscal year.
- Record adjusted EPS of $5.80 for fiscal year, up 20%.
- 4% organic volume growth in fiscal year despite challenges.
- Projected adjusted EPS for fiscal 2022 of $7.20 - $7.70.
- Strong cash flow from operations expected at $1.7 - $1.8 billion.
- 1% decline in organic volumes in Q4 due to supply chain issues.
- Operating income decreased due to a $66 million unfavorable price cost spread.
Fourth Quarter and Fiscal Year Highlights
(all comparisons made to the
-
Net sales growth of
22% and18% in the quarter and fiscal year, respectively -
Fiscal year organic volume growth of
4% ; HHS +5% , CPNA +4% , EM +4% and CPI +3% -
Fiscal year net income per share (EPS) up
28% to and adjusted EPS up$5.30 20% to ($5.80 including amortization of intangibles from acquisitions)$7.21 -
Cash flow from operations and free cash flow of
and$1.6B , respectively$904M -
Fiscal 2022 expecting
2% organic volume growth and adjusted EPS of -$7.20 (including amortization of intangibles from acquisitions)$7.70 -
Fiscal 2022 expecting cash flow from operations of
-$1.7 and free cash flow of$1.8B -$900M $1B
Berry’s Chairman and CEO
“We continue to invest in each of our businesses to build and maintain our world-class, low-cost, manufacturing base, with an emphasis on key growth markets and regions and continue to see incremental opportunity to invest organically in support of our unwavering commitment to global growth. The continued positive momentum from our investments in areas such as health and wellness, e-commerce, and food safety while driving more sustainable packaging, provide us the path to realize long-term consistent volume and earnings growth just as we delivered over the last several years.”
Consolidated Overview
The net sales growth of
The operating income decrease is primarily attributed to a
The net sales growth of
The operating income increase is primarily attributed to a decline in business integration expenses and other non-cash charges along with a decrease in selling, general, and administrative expense, partially offset by a
The net sales growth of
The operating income decrease is primarily attributed to a
Health, Hygiene, & Specialties
The net sales growth of
The operating income decrease is primarily attributed to a
Engineered Materials
The net sales growth of
The operating income decrease is primarily attributed to a
Fiscal Year 2021 Results
Consolidated Overview |
|
|
||
|
Fiscal Year |
|
|
|
(in millions of dollars) |
Current |
Prior |
$ Change |
% Change |
Net sales |
|
|
|
|
Operating income |
1,292 |
1,179 |
113 |
|
The net sales growth is primarily attributed to increased selling prices of
The operating income increase is primarily attributed to a
|
|
|||
|
Fiscal Year |
|
|
|
(in millions of dollars) |
Current |
Prior |
$ Change |
% Change |
Net sales |
|
|
|
|
Operating income |
317 |
273 |
44 |
|
The net sales growth in the
The operating income increase is primarily attributed to a
|
|
|||
|
Fiscal Year |
|
|
|
(in millions of dollars) |
Current |
Prior |
$ Change |
% Change |
Net sales |
|
|
|
|
Operating income |
276 |
275 |
1 |
- % |
The net sales growth in the
The operating income being flat is primarily attributed to a
Health, Hygiene & Specialties |
|
|||
|
Fiscal Year |
|
|
|
(in millions of dollars) |
Current |
Prior |
$ Change |
% Change |
Net sales |
|
|
|
|
Operating income |
398 |
295 |
103 |
|
The net sales growth in the Health, Hygiene & Specialties segment is primarily attributed to organic volume growth of
The operating income increase is primarily attributed to a
Engineered Materials |
|
|||
|
Fiscal Year |
|
|
|
(in millions of dollars) |
Current |
Prior |
$ Change |
% Change |
Net sales |
|
|
|
|
Operating income |
301 |
336 |
(35) |
(10)% |
The net sales growth in the Engineered Materials segment is primarily attributed to increased selling prices of
The operating income decrease is primarily attributed to a
Cash Flow and Balance Sheet
Our cash flow from operating activities increased to
Our total debt less cash and cash equivalents (or “net debt”) at the end of fiscal 2021 quarter was
Fiscal Year 2022 Guidance
For fiscal year 2022 Berry expects adjusted earnings per share (EPS) to be
Investor Conference Call
The Company will host a conference call today,
About Berry
At
Non-GAAP Financial Measures and Estimates
This press release includes non-GAAP financial measures such as operating EBITDA, Adjusted EBITDA, Adjusted net income, and free cash flow. A reconciliation of these non-GAAP financial measures to comparable measures determined in accordance with accounting principles generally accepted in
Forward Looking Statements
Statements in this release that are not historical, including statements relating to the expected future performance of the Company, are considered “forward looking” within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements because they contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “projects,” “estimates,” “projects,” “outlook,” “anticipates” or “looking forward,” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments.
Our actual results may differ materially from those that we expected due to a variety of factors, including without limitation: (1) risks associated with our substantial indebtedness and debt service; (2) changes in prices and availability of resin and other raw materials and our ability to pass on changes in raw material prices to our customers on a timely basis; (3) risks related to acquisitions or divestitures and integration of acquired businesses and their operations, and realization of anticipated cost savings and synergies; (4) risks related to international business, including foreign currency exchange rate risk and the risks of compliance with applicable export controls, sanctions, anti-corruption laws and regulations; (5) increases in the cost of compliance with laws and regulations, including environmental, safety, and climate change laws and regulations; (6) labor issues, including the potential labor shortages, shutdowns or strikes or the failure to renew effective bargaining agreements; (7) risks related to disruptions in the overall economy [,supply chains] and the financial markets that may adversely impact our business, including as a result of the COVID-19 pandemic; (8) risk of catastrophic loss of one of our key manufacturing facilities, natural disasters, and other unplanned business interruptions; (9) risks related to the failure of, inadequacy of, or attacks on our information technology systems and infrastructure; (10) risks that our restructuring programs may entail greater implementation costs or result in lower cost savings than anticipated; (11) risks related to future write-offs of substantial goodwill; (12) risks of competition, including foreign competition, in our existing and future markets; and (13) the other factors discussed in the section titled “Risk Factors” in our Annual Report on Form 10-K and subsequent filings with the
Consolidated Statements of Income (Unaudited) (in millions of dollars, except per share data amounts) |
|||||||||||
|
Quarterly Period Ended |
|
Fiscal Year Ended |
||||||||
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
||||
Net sales |
|
|
|
|
|
|
|
|
|||
Costs and expenses: |
|
|
|
|
|
|
|
||||
Cost of goods sold |
3,078 |
|
|
2,342 |
|
11,352 |
|
9,301 |
|||
Selling, general and administrative |
199 |
|
|
219 |
|
867 |
|
850 |
|||
Amortization of intangibles |
69 |
|
|
74 |
|
288 |
|
300 |
|||
Restructuring and transaction activities |
11 |
|
|
24 |
|
51 |
|
79 |
|||
Operating income |
312 |
|
|
349 |
|
1,292 |
|
1,179 |
|||
|
|
|
|
|
|
|
|
||||
Other expense (income), net |
6 |
|
|
25 |
|
51 |
|
31 |
|||
Interest expense, net |
79 |
|
|
96 |
|
336 |
|
435 |
|||
Income before income taxes |
227 |
|
|
228 |
|
905 |
|
713 |
|||
Income tax (benefit) expense |
(1 |
) |
|
33 |
|
172 |
|
154 |
|||
Net income |
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
||||
Net income per share: |
|
|
|
|
|
|
|
||||
Basic |
|
|
|
|
|
|
|
|
|||
Diluted |
1.64 |
|
|
1.44 |
|
5.30 |
|
4.14 |
|||
|
|
|
|
|
|
|
|
||||
Outstanding weighted-average shares: (in millions) |
|
|
|
|
|
|
|
||||
Basic |
135.4 |
|
|
133.1 |
|
134.6 |
|
132.6 |
|||
Diluted |
138.7 |
|
|
135.4 |
|
138.3 |
|
135.1 |
|||
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets (Unaudited) (in millions of dollars) |
|||
|
|
|
|
Assets: |
|
|
|
Cash and cash equivalents |
|
|
|
Accounts receivable, net |
1,879 |
|
1,469 |
Inventories |
1,907 |
|
1,268 |
Other current assets |
217 |
|
330 |
Property, plant, and equipment, net |
4,677 |
|
4,561 |
|
8,111 |
|
8,323 |
Total assets |
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity: |
|
|
|
Current liabilities, excluding debt |
|
|
|
Current and long-term debt |
9,460 |
|
10,237 |
Other long-term liabilities |
2,077 |
|
2,264 |
Stockholders’ equity |
3,180 |
|
2,092 |
Total liabilities and stockholders' equity |
|
|
|
Condensed Consolidated Statements of Cash Flows (Unaudited) (in millions of dollars) |
|||||
|
Fiscal Year Ended |
||||
|
|
|
|
||
|
|
|
|
||
Cash flows from operating activities: |
|
|
|
||
Net income |
|
|
|
|
|
Adjustments to reconcile net cash provided by operating activities: |
|
|
|
||
Depreciation |
566 |
|
|
545 |
|
Amortization of intangibles |
288 |
|
|
300 |
|
Non-cash interest |
32 |
|
|
27 |
|
Deferred income tax |
(73 |
) |
|
(96 |
) |
Share-based compensation expense |
40 |
|
|
33 |
|
Other non-cash operating activities, net |
49 |
|
|
53 |
|
Changes in working capital |
(55 |
) |
|
109 |
|
Net cash from operating activities |
1,580 |
|
|
1,530 |
|
|
|
|
|
||
Cash flows from investing activities: |
|
|
|
||
Additions to property, plant, and equipment, net |
(676 |
) |
|
(583 |
) |
Divestiture of businesses |
165 |
|
|
— |
|
Settlement of net investment hedges |
— |
|
|
281 |
|
Other investing activities |
— |
|
|
(14 |
) |
Net cash from investing activities |
(511 |
) |
|
(316 |
) |
|
|
|
|
||
Cash flows from financing activities: |
|
|
|
||
Repayments on long-term borrowings |
(3,496 |
) |
|
(2,436 |
) |
Proceeds from long-term borrowings |
2,716 |
|
|
1,202 |
|
Proceeds from issuance of common stock |
60 |
|
|
30 |
|
Debt financing costs |
(21 |
) |
|
(16 |
) |
Net cash from financing activities |
(741 |
) |
|
(1,220 |
) |
Effect of currency translation on cash |
13 |
|
|
6 |
|
Net change in cash and cash equivalents |
341 |
|
|
— |
|
Cash and cash equivalents at beginning of period |
750 |
|
|
750 |
|
Cash and cash equivalents at end of period |
|
|
|
|
Condensed Consolidated Financial Statements Segment Information (Unaudited) (in millions of dollars) |
||||||||||||
|
Quarterly Period Ended |
|||||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
|||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
83 |
|
|
60 |
|
|
47 |
|
25 |
|
215 |
|
Restructuring and transaction activities (1) |
12 |
|
|
(1 |
) |
|
— |
|
— |
|
11 |
|
Other non-cash charges |
(11 |
) |
|
1 |
|
|
1 |
|
1 |
|
(8 |
) |
Operating EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Period Ended |
||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
76 |
|
57 |
|
46 |
|
28 |
|
207 |
Restructuring and transaction activities (1) |
18 |
|
5 |
|
— |
|
1 |
|
24 |
Other non-cash charges |
2 |
|
1 |
|
1 |
|
2 |
|
6 |
Operating EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Primarily includes transaction activity costs related to the RPC acquisition. |
|
|
||
Note: For comparison purposes to the |
Condensed Consolidated Financial Statements Segment Information (Unaudited) (in millions of dollars) |
|||||||||||
|
Fiscal Year Ended |
||||||||||
|
Consumer
|
|
Consumer
|
|
Health,
|
|
Engineered
|
|
Total |
||
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Operating income |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
341 |
|
224 |
|
177 |
|
|
112 |
|
|
854 |
Restructuring and transaction activities (1) |
56 |
|
— |
|
(1 |
) |
|
(4 |
) |
|
51 |
Other non-cash charges (2) |
— |
|
10 |
|
9 |
|
|
8 |
|
|
27 |
Operating EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Year Ended |
||||||||
|
Consumer
|
|
Consumer
America |
|
Health,
|
|
Engineered
|
|
Total |
Net sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
315 |
|
230 |
|
184 |
|
116 |
|
845 |
Restructuring and transaction activities (1) |
55 |
|
11 |
|
6 |
|
7 |
|
79 |
Other non-cash charges (2) |
31 |
|
10 |
|
5 |
|
8 |
|
54 |
Operating EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Primarily includes transaction activity costs related to the RPC acquisition. |
|
(2) |
Other non-cash charges, for the current and prior years, primarily include stock compensation expense. |
|
Note: For comparison purposes to the 2020 fiscal year, Operating EBITDA margins for the fiscal year ended |
Reconciliation Schedules (Unaudited) (in millions of dollars, except per share data) |
|||||||||
|
Quarterly Period Ended |
|
Fiscal Year Ended |
||||||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
||
Net income |
|
|
|
|
|
|
|
|
|
Add: other expense, net |
6 |
|
|
25 |
|
51 |
|
|
31 |
Add: interest expense, net |
79 |
|
|
96 |
|
336 |
|
|
435 |
Add: income tax (benefit) expense |
(1 |
) |
|
33 |
|
172 |
|
|
154 |
Operating income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Add: non-cash amortization from 2006 private sale |
6 |
|
|
6 |
|
24 |
|
|
25 |
Add: restructuring and transaction activities |
11 |
|
|
24 |
|
51 |
|
|
79 |
Add: other non-cash charges |
(8 |
) |
|
6 |
|
27 |
|
|
54 |
Adjusted operating income (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Add: depreciation |
146 |
|
|
133 |
|
566 |
|
|
545 |
Add: amortization of intangibles |
63 |
|
|
68 |
|
264 |
|
|
275 |
Operating EBITDA (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
Less: divestitures and prior year extra days (1) |
|
|
|
|
(30 |
) |
|
|
|
Adjusted EBITDA (6) |
|
|
|
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
|
|
|
|
|
Net additions to property, plant, and equipment |
(156 |
) |
|
(165 |
) |
|
(676 |
) |
|
Free cash flow (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per diluted share |
|
|
|
|
|
|
|
|
|
|
|
Other expense, net |
0.04 |
|
|
0.18 |
|
|
0.37 |
|
|
0.23 |
|
Non-cash amortization from 2006 private sale (2) |
0.04 |
|
|
0.04 |
|
|
0.18 |
|
|
0.19 |
|
Restructuring and transaction activities |
0.08 |
|
|
0.18 |
|
|
0.37 |
|
|
0.58 |
|
Other non-cash charges (3) |
— |
|
|
— |
|
|
— |
|
|
0.14 |
|
Non-comparable tax items (4) |
(0.22 |
) |
|
(0.15 |
) |
|
(0.22 |
) |
|
(0.15 |
) |
Income tax impact on items above |
(0.03 |
) |
|
(0.10 |
) |
|
(0.20 |
) |
|
(0.28 |
) |
Adjusted net income per diluted share (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Comparable for Fiscal 2022 |
|
|
|
|
|
|
|
||||
Adjustment for additional days in fiscal 2021 |
— |
|
|
— |
|
|
(0.02 |
) |
|
— |
|
Amortization of intangibles from acquisitions (5)(tax affected) |
0.34 |
|
|
0.38 |
|
|
1.43 |
|
|
1.53 |
|
Adjusted net income per diluted share (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|||
Cash flow from operating activities |
|
|||
Additions to property, plant, and equipment |
(800) |
|||
Free cash flow (6) |
|
|||
|
|
(1) |
Represents operating EBITDA related to divestments within the last twelve months and extra days in the prior fiscal year. |
|
(2) |
Amortization excludes non-cash amortization from the 2006 private sale of |
|
(3) |
Represents an adjustment for a |
|
(4) |
During the current and prior fiscal years, the Company obtained certain tax benefits of |
|
(5) |
Amortization of intangibles from acquisition will be added back for fiscal year 2022 and going forward to better align our calculation of adjusted EPS with peers. |
|
(6) |
Supplemental financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in |
|
We define “free cash flow” as cash flow from operating activities less additions to property, plant, and equipment. We believe free cash flow is useful to an investor in evaluating our liquidity because free cash flow and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s liquidity. We also believe free cash flow is useful to an investor in evaluating our liquidity as it can assist in assessing a company’s ability to fund its growth through its generation of cash. |
||
Adjusted EBITDA is used by our lenders for debt covenant compliance purposes. We also use Adjusted EBITDA and Operating EBITDA among other measures to evaluate management performance and in determining performance-based compensation. Adjusted EBITDA and Operating EBITDA and similar measures are widely used by investors, securities analysts, and other interested parties in our industry to measure a company’s performance. We also believe EBITDA and Adjusted net income are useful to an investor in evaluating our performance without regard to revenue and expense recognition, which can vary depending upon accounting methods. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211118005284/en/
Director, Head of Investor Relations
+1 (812) 306 2964
ir@berryglobal.com
Source:
FAQ
What were Berry Global's Q4 2021 financial results?
What is the adjusted EPS for Berry Global for fiscal year 2021?
What is Berry Global's guidance for fiscal year 2022?
How much cash flow is Berry Global expecting for fiscal year 2022?